-

BIODESIX, INC. BDSX INVESTORS: Contact Kirby McInerney LLP About the Firm’s Securities Investigation Following 57% Share Drop

NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP reminds investors of its investigation on behalf of Biodesix, Inc. (“Biodesix” or the “Company”) (NASDAQ: BDSX) investors concerning the Company’s and/or members of its senior management’s possible violation of the federal securities laws or other unlawful business practices.

[LEARN MORE ABOUT THE FIRM’S INVESTIGATION]

What Happened?

On November 5, 2026, Biodesix announced its third quarter 2026 financial results, reporting third quarter revenue of $24.0 million, below analyst expectations, and reducing its full-year 2026 revenue guidance to $101 million to $103 million from its prior guidance of $108 million to $114 million. Kinross CEO Scott Hutton stated that “execution and timing challenges,” specifically “fewer contributing sales representatives than planned, greater-than-anticipated seasonality in primary care and customer-delayed start of several development services projects,” led to quarterly results that “did not meet our expectations.” Hutton further explained the Company averaged 101 sales representatives during the quarter, below the Company’s second quarter average, due to higher turnover and a hiring pace that did not keep up with attrition and planned growth. Hutton stated, “As a result, a greater portion of our commercial effort was focused on maintaining existing accounts, reducing our capacity to acquire new ordering physicians.” On this news, the price of Biodesix shares declined by $11.31 per share, or approximately 57%, from $19.84 per share on November 5, 2026 to close at $8.53 on November 6, 2026.

What Should I Do?

At this stage, no lawsuit has been filed. The investigation is ongoing to determine whether claims may be brought under federal securities laws.

If you purchased or otherwise acquired Biodesix securities, have information, or would like to learn more about this investigation, please contact Lauren Molinaro of Kirby McInerney LLP by email at investigations@kmllp.com, or fill out the contact form below, to discuss your rights or interests with respect to these matters at no cost.

[LEARN MORE ABOUT SECURITIES CLASS ACTIONS]

Kirby McInerney LLP is a New York-based plaintiffs’ law firm concentrating in securities, antitrust, whistleblower, and consumer litigation. The firm’s efforts on behalf of shareholders in securities litigation have resulted in recoveries totaling billions of dollars. Additional information about the firm can be found on Kirby McInerney LLP’s website.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contacts

Kirby McInerney LLP

NASDAQ:BDSX

Release Versions
$Cashtags

Contacts

More News From Kirby McInerney LLP

KGC INVESTORS: Contact Kirby McInerney LLP About the Securities Fraud Lawsuit Filed on Behalf of Kinross Gold Corporation Shareholders

NEW YORK--(BUSINESS WIRE)--Kirby McInerney LLP reminds investors who purchased Kinross Gold Corporation (“Kinross” or the “Company”) (NYSE: KGC) securities to contact Lauren Molinaro of Kirby McInerney LLP by email at investigations@kmllp.com, or fill out the contact form below by January 5, 2027, to discuss your rights or interests in the securities fraud class action at no cost. [CONTACT THE FIRM IF YOU SUFFERED A LOSS] What Is The Lawsuit About? The lawsuit has been filed on behalf of invest...

OI Investors: O-I Glass, Inc. Shares Declined By $1.36 On July 29, 2026 ‒ Contact Kirby McInerney LLP to Discuss Your Rights

NEW YORK--(BUSINESS WIRE)--If you have suffered a loss on your O-I Glass, Inc. (“O-I Glass” or the “Company”) (NYSE: OI) investment, contact Lauren Molinaro of Kirby McInerney LLP by email at investigations@kmllp.com, or fill out the contact form below to discuss your rights or interests in the securities fraud class action lawsuit at no cost. Investors have until December 28, 2026 to ask the Court to appoint them as lead plaintiff.[CONTACT THE FIRM IF YOU SUFFERED A LOSS]What Is The Lawsuit Abo...

CVRX INVESTORS: Contact Kirby McInerney LLP About the Securities Fraud Lawsuit Filed on Behalf of CVRx, Inc. Shareholders

NEW YORK--(BUSINESS WIRE)--Kirby McInerney LLP reminds investors who purchased CVRx, Inc. (“CVRx” or the “Company”) (NASDAQ: CVRX) securities to contact Lauren Molinaro of Kirby McInerney LLP by email at investigations@kmllp.com, or fill out the contact form below by January 8, 2027, to discuss your rights or interests in the securities fraud class action at no cost.[CONTACT THE FIRM IF YOU SUFFERED A LOSS]What Is The Lawsuit About?The lawsuit has been filed on behalf of investors who purchased...
Back to Newsroom